Medrhythms
Business Services · Maine, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
183 Middle St Ste 300, Portland, Maine, ...Phone Number
(617) 356-7822Website
www.medrhythms.comRevenue
$9.5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Medrhythms
MedRhythms is dedicated to developing next-generation neurotherapeutics to improve brain health and assist individuals dealing with neurologic injuries and walking disabilities. Their proprietary technology platform leverages Rhythmic Auditory Stimulation (RAS), combining music, sensors, and software to enhance mobility and functional outcomes for patients with conditions such as stroke and Parkinson's disease. The company aims to transform patient care by providing digital therapeutics through an extensive and culturally rich music library, personalized for each user. MedRhythms is committed to reclaiming independence and enhancing the quality of life for millions affected by neurologic gait disorders worldwide.Explore more
Medrhythms Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Medrhythms your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if Medrhythms is spiking on competitors!
Earning: See what the market has to say on Medrhythms recently announced quarterly report
Product Launch: Get notified when Medrhythms launches new products
Funding: Get notified immidiatlly once Medrhythms has new funding data
Check if Medrhythms has recently received funding, and reach out quickly before it becomes old news!
Click to see if Medrhythms had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at Medrhythms
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Medrhythms, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Find VP level buyers at Medrhythms
Find 3 more new buyers
Compare Similar Companies to Medrhythms
Compare insights from companies similar to Medrhythms, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
<$5M
11-50
Private
<$5M
2005
CL
Cynthia LevinthalPrincipal Consultant. Neural Stem Cell Therapies. Clinical Trials
Company Profile Activity
Activity Insights
Medrhythms is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Medrhythms is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Medrhythms.
Medrhythms financials insights
Gather financial insights about Medrhythms, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2018
Series A
$5.3M
2021
Series B
$27M
2026
Private Equity
$3.3M
Medrhythms Tech Stack
A closer look at the technologies used by Medrhythms
See more technologies
Most Recent Scoops
Project
Laboratory Operations, Medical Research, Clinical Operations
Funding
Funding
Lateral Move
Executive Move
Executive Moves, Lateral Move
New Hire
Executive Move
Executive Moves, New Hire
New Hire
Executive Move
Executive Moves, New Hire
Medrhythms News & Media
MedRhythms Announces Availability of Movive™ for Parkinson's Disease (PD) for Veterans
PORTLAND, Maine, April 2, 2025 /PRNewswire/ -- MedRhythms today announced that Movive™, the company's neurorehabilitation system to support gait rehabilitation and motor function in adults with Parkinson's disease (PD), is now available for order within the U.S. Department of Veteran...MedRhythms Announces FDA Class II Listing for Movive™ to Support Gait Rehabilitation and Motor Function for Parkinson's Disease
PORTLAND, Maine, March 6, 2025 /PRNewswire/ -- MedRhythms today announced that MR-005, the company's neurorehabilitation system to support gait rehabilitation and motor function in adults with Parkinson's disease (PD), has been listed as a Class II, Rx-only medical device with the U.S....MedRhythms Hires Joel Behnke as Chief Commercial Officer - PR Newswire
/PRNewswire/ -- MedRhythms, Inc. today announced that Joel Behnke has been hired as Chief Commercial Officer. Mr. Behnke brings over two decades of commercial...MedRhythms' InTandem® Rehabilitation System for Chronic Stroke Gait Impairment Receives Final Medicare Payment Determination from CMS
The pricing determination for HCPCS code E3200 will take effect on April 1, 2025 PORTLAND, Maine, Jan. 16, 2025 /PRNewswire/ -- MedRhythms, Inc. today announced that InTandem®, the company's flagship rehabilitation system for chronic stroke gait impairment, received a final pricing...
Read more news
Top Business Services Companies
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Medrhythms
Sign Up For FreeTo access detailed company insights
MedRhythms is dedicated to developing next-generation neurotherapeutics to improve brain health and assist individuals dealing with neurologic injuries and walking disabilities. Their proprietary technology platform leverages Rhythmic Auditory Stimulation (RAS), combining music, sensors, and software to enhance mobility and functional outcomes for... Read More
